Found: 30
Select item for more details and to access through your institution.
EU-Zulassung für Kisqali® (Ribociclib) als Erstlinientherapie des HR+/HER2-, lokal fortgeschrittenen oder metastasierten Mammakarzinoms erhalten.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 638
- Publication type:
- Article
Schlüssel zur CLL-Primärtherapie?
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 638
- Publication type:
- Article
Das Multiple Myelom besser verstehen -- drei Erklärfilme für Patienten und Angehörige ab sofort online.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 637
- Publication type:
- Article
Handfeste Optionen bei EGFR-Mutationen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 637
- By:
- Publication type:
- Article
23. José Carreras Gala in München.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 627
- Publication type:
- Article
Zweite Phase-III-Studie zeigt signifikant verlängertes Gesamtüberleben von Patienten mit rezidiviertem multiplem Myelom unter einem Carfilzomib (Kyprolis®)-Behandlungsregime.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 636
- Publication type:
- Article
Heilungschancen bei APL durch Therapie der Koagulopathie weiter verbessern.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 636
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2017
- Publication type:
- Correction Notice
Neues aus der ersten Jahreshälfte 2017.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 634
- By:
- Publication type:
- Article
Osimertinib verbessert das progressionsfreie Überleben bei Lungenkrebs signifikant und klinisch relevant.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 636
- Publication type:
- Article
Darzalex®: Neuer Standard in der Zweitlinientherapie.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 631, doi. 10.1159/000481599
- Publication type:
- Article
«Wir wollen die Forschung in der Immunonkologie beschleunigen und Patienten eine individuell zugeschnittene Therapie ermöglichen».
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 635
- By:
- Publication type:
- Article
Daten zum Wirkmechanismus liefern Ansatzpunkte für weitere Einsatzmöglichkeiten.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 628, doi. 10.1159/000481597
- By:
- Publication type:
- Article
Monatsthema im Oktober: Mobile Helfer - Können Apps bei Vorsorge und Krebstherapie unterstützen?
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 626
- Publication type:
- Article
Praktische Erfahrungen mit Kadcyla®▼ in der Therapie von Patientinnen mit HER2- und Hormonrezeptor-positivem Mammakarzinom.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 633
- By:
- Publication type:
- Article
Methadon in der Krebstherapie: Hohe Erwartungen können nicht erfüllt werden.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 625
- Publication type:
- Article
Erstes Rituximab-Biosimilar ermöglicht sichere und qualitativ hochwertige Behandlung von B-Zell-Lymphomen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 629, doi. 10.1159/000481598
- By:
- Publication type:
- Article
In 4 Jahren vom 'Breakthrough of the year' bis zur ersten Zulassung: Die Hämatologie und Onkologie bleibt ein extrem innovatives Fachgebiet.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 623
- Publication type:
- Article
The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 616, doi. 10.1159/000478935
- By:
- Publication type:
- Article
Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Specific Characteristics of Patients with Advanced Genitourinary Cancer Receiving Specialized Inpatient Palliative Care.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 609, doi. 10.1159/000478934
- By:
- Publication type:
- Article
Clinical Correlates and Prognostic Significance of IL-8, sIL-2R, and Immunoglobulin-Free Light Chain Levels in Patients with Myelofibrosis.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 574, doi. 10.1159/000477253
- By:
- Publication type:
- Article
Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 594, doi. 10.1159/000478100
- By:
- Publication type:
- Article
Magnetic Resonance Features and Characteristic Vascular Pattern of Alveolar Soft-Part Sarcoma.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 580, doi. 10.1159/000477443
- By:
- Publication type:
- Article
Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAF<sup>V600E</sup> Mutation.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 586, doi. 10.1159/000477909
- By:
- Publication type:
- Article
Increased Percentage of mo-MDSCs in Human Peripheral Blood May Be a Potential Indicator in the Diagnosis of Breast Cancer.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 603, doi. 10.1159/000478933
- By:
- Publication type:
- Article
OPDIVO® + YERVOY®: Paradigmenwechsel bei der Behandlung von Hirnmetastasen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 6
- Publication type:
- Article
OPDIVO® - der neue Standard in der Zweitlinien-Therapie.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 4
- Publication type:
- Article
Spendentour «Country 2 Country 4 Cancer»: Engagement für Krebspatienten.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 7
- Publication type:
- Article
OPDIVO® in der Urologie jetzt bei zwei Tumorentitäten zugelassen.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 10, p. 2
- Publication type:
- Article